Delaying standard combined chemoradiotherapy after surgical resection does not impact survival in newly diagnosed glioblastoma patients

Abstract Background To assess the influence of the time interval between surgical resection and standard combined chemoradiotherapy on survival in newly diagnosed and homogeneously treated (surgical resection plus standard combined chemoradiotherapy) glioblastoma patients; while controlling confound...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiotherapy and oncology 2016-01, Vol.118 (1), p.9-15
Hauptverfasser:	Louvel, Guillaume, Metellus, Philippe, Noel, Georges, Peeters, Sophie, Guyotat, Jacques, Duntze, Julien, Le Reste, Pierre-Jean, Dam Hieu, Phong, Faillot, Thierry, Litre, Fabien, Desse, Nicolas, Petit, Antoine, Emery, Evelyne, Voirin, Jimmy, Peltier, Johann, Caire, François, Vignes, Jean-Rodolphe, Barat, Jean-Luc, Langlois, Olivier, Menei, Philippe, Dumont, Sarah N, Zanello, Marc, Dezamis, Edouard, Dhermain, Frédéric, Pallud, Johan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Alkylating - therapeutic use Brain Neoplasms - drug therapy Brain Neoplasms - radiotherapy Brain Neoplasms - surgery Chemoradiotherapy Cognitive science Combined Modality Therapy Disease-Free Survival Female Glioblastoma Glioblastoma - surgery Glioblastoma - therapy Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Neuroscience Prognostic factors Proportional Hazards Models Radiotherapy Retrospective Studies Standard combined chemoradiotherapy Temozolomide Time Time interval
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!